|Articles|June 11, 2018

ICON Enhances Endpoint Adjudication Services for Clinical Trials

ICON plc, a global provider of drug development and commercialization solutions and services, announced it has signed an agreement with AG Mednet to use Judi, a comprehensive electronic endpoint adjudication system, to manage workflow and ensure data quality for enhanced endpoint event adjudication services.

Read the full release here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.